Childhood Survivors Of High-Risk Neuroblastoma Show Signs Of Immune Recovery And Not Immunosenescence
EUROPEAN JOURNAL OF IMMUNOLOGY(2020)
摘要
Neuroblastoma survivors show signs of immunosenescence early after therapy in CD8(+)T cell compartment and elevated plasma TNF-alpha but in later follow-up immune recovery comes into play. Whether the recovery phenotype is long lasting or transient remains to be elucidated, however, late adverse effects often occur in childhood cancer survivors.
更多查看译文
关键词
adverse late effects, childhood, immune recovery, immunosenescence, neuroblastoma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要